Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01650922
First received: July 24, 2012
Last updated: July 25, 2012
Last verified: July 2012
  Purpose

To look for patterns of polymorphisms in DNA repair in both germline and tumor cells samples.


Condition Intervention
Brain Cancer
Procedure: phlebotomy
Procedure: biopsy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples

Resource links provided by NLM:


Further study details as provided by Stanford University:

Biospecimen Retention:   Samples With DNA

the investigators will sample a single blood sample or buccal swab and if obtained at the time of diagnosis, brain tumor biopsy.


Enrollment: 4
Study Start Date: September 2005
Study Completion Date: September 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 24 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pediatric cancer patients diagnosed with brain tumors

Criteria

Inclusion Criteria:Pediatric cancer patients diagnosed with brain tumors

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01650922

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: James M Ford Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT01650922     History of Changes
Other Study ID Numbers: PEDSBRN0004, 96447, PEDSBRN0004
Study First Received: July 24, 2012
Last Updated: July 25, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Brain Neoplasms
Central Nervous System Neoplasms
Nervous System Neoplasms
Neoplasms by Site
Neoplasms
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on April 22, 2014